Autres langues Horizon Discovery Group plc

Actions

HZD

GB00BK8FL363

Temps Différé London S.E. Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^GBX	-.--%		-.--%	+23,00 %

2022	Le Medical Device Innovation Consortium (MDIC) s'associe à Horizon Discovery de PerkinElmer pour améliorer la précision des diagnostics de cancer basés sur le séquençage de nouvelle génération	CI
2020	Horizon Discovery s'envole de 110 % après son acquisition par PerkinElmer pour 366 millions de dollars.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Medical Device Innovation Consortium Partners with PerkinElmer's Horizon Discovery to Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics	19/10/22
Horizon Discovery : Acquisition by PerkinElmer Completes	23/12/20
PerkinElmer (UK) Holdings Ltd. completed the acquisition of Horizon Discovery Group plc from Inclusive Capital Partners, L.P. and others.	23/12/20
Horizon Discovery : Takeover by PerkinElmer Gets Court Approval	22/12/20
GFGW LLC : - Form 8.3 - Horizon Discovery Group Plc	11/12/20
Horizon Discovery : Soars 110% on Acquisition by PerkinElmer in $366 Million Deal	02/11/20
PerkinElmer (UK) Holdings Ltd. agreed to acquire Horizon Discovery Group plc from Inclusive Capital Partners, L.P. and others for approximately £290 million.	02/11/20
Horizon Discovery Group plc Reports Earnings Results for the Half Year Ended June 30, 2020	17/08/20
Horizon Discovery : introduces single cell RNAseq-linked CRISPR screening service	04/08/20
Horizon Discovery Group plc Announces the Addition of Single Cell RNAseq-Linked Pooled CRISPR Screening to Its CRISPR Screening Services Portfolio	04/08/20
Horizon Discovery : Licenses CHOSOURCE Platform to Truebinding for Development and Commercialization of Multiple Biotherapeutics	29/07/20
Horizon Discovery Group plc Licenses Chosource Platform to TrueBinding, Inc for Development and Commercialization of Multiple Biotherapeutics	29/07/20
Horizon Discovery Group plc Provides Group Revenue Guidance for the Six Months Ended June 30, 2020	29/07/20
Horizon Discovery : Introduces Cas9 and dCas9-VPR Stable Cell Lines to Simplify and Accelerate CRISPR Gene Editing Workflows	07/07/20
Horizon Discovery Group plc Introduces Cas9 and dCas9-VPR Stable Cell Lines to Simplify and Accelerate CRISPR Gene Editing Workflows	07/07/20
Horizon Discovery : Rentschler Biopharma Licenses Horizon Discovery’s CHOSOURCE Platform to Complement Cell Line Development Offering for Difficult-To-Express Proteins	19/05/20
Rentschler Biopharma Licenses Horizon Discovery's Chosource Platform to Complement Cell Line Development Offering for Difficult-To-Express Proteins	19/05/20
Horizon Discovery Group plc Announces Board Changes	01/05/20
Horizon Discovery : Full Year Unaudited Results 2019	27/04/20
Horizon Discovery Group plc Unable to Provide Guidance for the Full Year of 2020	27/04/20

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Horizon Discovery Group plc

Actions

HZD

GB00BK8FL363

Autres langues

Filtres